University of Patras
Μελέτη του ρόλου της σεροτονίνης και της σηματοδότησης μέσω Wnt και BMP μονοπατιών στον έλεγχο της οστεοβλαστικής δραστηριότητας σε ασθενείς με αγκυλοποιητική σπονδυλίτιδα
Abstract
dc:descriptionEvidence suggests that serotonin is an inhibitor of bone formation. We aimed to assess i) serum serotonin levels in patients with ankylosing spondylitis (AS), a prototype bone forming disease, compared to patients with rheumatoid arthritis (RA) and healthy subjects ii) the effect(s) of TNFα blockers on serum serotonin levels in patients with AS and RA and iii) the effect(s) of serum of AS patients on serotonin signaling. Serum serotonin levels were measured in 47 patients with AS, 28 patients with RA and 40 healthy subjects by RIA; t-test was used to assess differences between groups. The effect of serum on serotonin signaling was assessed using the human osteoblastic cell line Saos2, evaluating levels of phospho-CREB by western immunoblots. Serotonin serum levels were significantly lower in patients with AS compared to healthy subjects (mean ± SEM ng/ml: 122.9 ± 11.6 vs 177.4 ± 24.58, p=0.038) and patients with RA (mean ± SEM ng/ml: 244.8 ± 37.5, p=0.0004). Patients with AS receiving TNFα blockers had significantly lower serotonin levels compared to patients with AS not on such treatment (mean ± SEM ng/ml: 95.8 ± 14.9 vs 149.2 ± 16.0, p=0.019). Serotonin serum levels were inversely correlated with pCREB induction in osteoblast-like Saos-2 cells. Serotonin levels are low in patients with AS and decrease even further during anti-TNFα treatment. Differences in serotonin levels are shown to have a functional impact on osteoblast-like Saos-2 cells. Therefore, serotonin may be involved in new bone formation in AS.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Klavdianou, Kalliopi
- Κλαυδιανού, Καλλιόπη
Subjects
dc:subject × 18- Αγκυλοποιητική σπονδυλίτιδα
- Σεροτονίνη
- Νέος οστικός σχηματισμός
- Οστεοβλαστογένεση
- Σπονδυλοαρθροπάθειες
- Αντι-TNF-α θεραπεία
- TNF-α αναστολείς
- Ankylosing spondylitis
- Serotonin
- NEW BONE FORMATION
- OSTEOBLASTOGENESIS
- Spondyloarthropathies
- ANTI-TNFa TREATMENT
- TNFa BLOCKER
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39266